pilsicainide has been researched along with Brugada ECG Pattern in 32 studies
pilsicainide: structure given in first source
pilsicainide : A secondary carboxamide resulting from the formal condensation of the amino group of 2,6-dimethylaniline with the carboxy group of (tetrahydro-1H-pyrrolizin-7a(5H)-yl)acetic acid. It is a sodium channel blocker which is used as an antiarrhythmic drug for the management of atrial tachyarrhythmias in Japan.
Excerpt | Relevance | Reference |
---|---|---|
"Pilsicainide induced VA in some patients with Brugada syndrome, but this result may not be used as a parameter of the risk stratification of Brugada syndrome." | 7.74 | Incidence and initial characteristics of pilsicainide-induced ventricular arrhythmias in patients with Brugada syndrome. ( Aizawa, Y; Chinushi, M; Furushima, H; Izumi, D; Komura, S; Tanabe, Y; Washizuka, T, 2007) |
" We investigated the association between spontaneous ventricular fibrillation (VF) occurrence and TWA after pilsicainide, a sodium channel blocker administration in BS patients." | 5.13 | Clinical significance of macroscopic T-wave alternans after sodium channel blocker administration in patients with Brugada syndrome. ( Banba, K; Kusano, KF; Miura, D; Morita, H; Nagase, S; Nakamura, K; Nishii, N; Ohe, T; Tada, T; Watanabe, A, 2008) |
"We administered intravenous pilsicainide to 245 consecutive patients with Brugada syndrome (181 patients with spontaneous type 1 ECG, 64 patients with non-type 1 ECG)." | 3.88 | Prognostic Significance of the Sodium Channel Blocker Test in Patients With Brugada Syndrome. ( Ito, H; Kawada, S; Miyamoto, M; Morimoto, Y; Morita, H; Nakagawa, K; Nishii, N; Tachibana, M; Ueoka, A; Watanabe, A, 2018) |
"Administration of pilsicainide, a class IC antiarrhythmic agent, caused Brugada- type ST elevation in a 66-year-old Japanese male who presented with paroxysmal atrial fibrillation (PAF), type I atrial flutter and inducible ventricular fibrillation (VF) during electrophysiological study." | 3.83 | A Novel SCN5A Mutation Associated with Drug Induced Brugada Type ECG. ( Ai, T; Horie, M; Itoh, H; Makiyama, T; Shimizu, A; Turker, I; Ueyama, T; Vatta, M, 2016) |
"Pilsicainide induced VA in some patients with Brugada syndrome, but this result may not be used as a parameter of the risk stratification of Brugada syndrome." | 3.74 | Incidence and initial characteristics of pilsicainide-induced ventricular arrhythmias in patients with Brugada syndrome. ( Aizawa, Y; Chinushi, M; Furushima, H; Izumi, D; Komura, S; Tanabe, Y; Washizuka, T, 2007) |
"Frequent premature ventricular complexes (PVCs) with two different left bundle branch block patterns developed during ST segment elevation." | 1.35 | Pilsicainide-induced ST segment elevation and ST segment depression in two patients with variant forms of Brugada-type electrocardiographic abnormalities. ( Aizawa, Y; Chinushi, M; Furushima, H; Izumi, D; Tagawa, M, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 16 (50.00) | 29.6817 |
2010's | 15 (46.88) | 24.3611 |
2020's | 1 (3.13) | 2.80 |
Authors | Studies |
---|---|
Hasebe, H | 1 |
Yokoya, T | 1 |
Murakoshi, N | 1 |
Kurebayashi, N | 1 |
Kakihara, J | 1 |
Takagi, M | 3 |
Hayashi, Y | 1 |
Tatsumi, H | 3 |
Doi, A | 3 |
Yoshiyama, M | 3 |
Ueoka, A | 1 |
Morita, H | 5 |
Watanabe, A | 3 |
Morimoto, Y | 1 |
Kawada, S | 1 |
Tachibana, M | 1 |
Miyamoto, M | 1 |
Nakagawa, K | 1 |
Nishii, N | 3 |
Ito, H | 1 |
Nagayama, T | 1 |
Nagase, S | 3 |
Kamakura, T | 2 |
Wada, M | 2 |
Ishibashi, K | 2 |
Inoue, YY | 1 |
Miyamoto, K | 2 |
Noda, T | 2 |
Aiba, T | 2 |
Takaki, H | 2 |
Sugimachi, M | 1 |
Shimizu, W | 2 |
Noguchi, T | 1 |
Yasuda, S | 2 |
Kamakura, S | 2 |
Kusano, K | 2 |
Nakajima, I | 1 |
Okamura, H | 1 |
Ogawa, H | 1 |
Makiyama, T | 2 |
Kimura, T | 1 |
Yamasaki, H | 1 |
Tada, H | 1 |
Sekiguchi, Y | 2 |
Aonuma, K | 1 |
Turker, I | 1 |
Vatta, M | 1 |
Itoh, H | 1 |
Ueyama, T | 5 |
Shimizu, A | 4 |
Ai, T | 1 |
Horie, M | 1 |
Kofune, M | 2 |
Watanabe, I | 2 |
Ashino, S | 2 |
Ohkubo, K | 2 |
Okumura, Y | 2 |
Kofune, T | 1 |
Nakai, T | 2 |
Hirayama, A | 2 |
Omichi, C | 1 |
Fujimoto, N | 1 |
Kawasaki, A | 1 |
Kasai, A | 1 |
Chinushi, M | 2 |
Tagawa, M | 1 |
Izumi, D | 2 |
Furushima, H | 2 |
Aizawa, Y | 2 |
Shimeno, K | 2 |
Maeda, K | 2 |
Nakagawa, E | 1 |
Mizobuchi, M | 1 |
Enjoji, Y | 1 |
Nakamura, S | 1 |
Muranishi, H | 1 |
Utsunomiya, M | 1 |
Funatsu, A | 1 |
Kobayashi, T | 1 |
Ogawa, R | 1 |
Kishi, R | 2 |
Takagi, A | 2 |
Sakaue, I | 1 |
Takahashi, H | 1 |
Matsumoto, N | 1 |
Masuhara, K | 1 |
Nakazawa, K | 2 |
Kobayashi, S | 1 |
Miyake, F | 2 |
Echizen, H | 1 |
Zipes, DP | 2 |
Morita, ST | 2 |
Wu, J | 2 |
Sugi, N | 3 |
Yoshiga, Y | 3 |
Doi, M | 1 |
Ohmiya, T | 1 |
Ohno, M | 1 |
Yoshida, M | 1 |
Matsuzaki, M | 4 |
Hisada, T | 1 |
Miyagawa, T | 1 |
Yakushiji, T | 1 |
Tsujimoto, T | 1 |
Sakai, M | 1 |
Adachi, T | 1 |
Ikewaki, K | 1 |
Ogata, K | 1 |
Ohsuzu, F | 1 |
Sakurai, Y | 1 |
Nagashima, K | 1 |
Kunimoto, S | 1 |
Kasamaki, Y | 1 |
Murata, K | 1 |
Tanaka, T | 1 |
Nose, Y | 1 |
Wada, Y | 1 |
Ikeda, T | 1 |
Abe, A | 1 |
Yusu, S | 1 |
Nakamura, K | 3 |
Ishiguro, H | 1 |
Mera, H | 1 |
Yotsukura, M | 1 |
Yoshino, H | 1 |
Yodogawa, K | 1 |
Morita, N | 1 |
Kobayashi, Y | 1 |
Takayama, H | 1 |
Ohara, T | 1 |
Katoh, T | 1 |
Takano, T | 1 |
Yamagata, T | 1 |
Esato, M | 2 |
Ohmura, M | 1 |
Kanemoto, M | 1 |
Kametani, R | 1 |
Sawa, A | 2 |
Suzuki, S | 2 |
DeschĂȘnes, I | 1 |
Laurita, KR | 1 |
Sakurai, T | 1 |
Osada, K | 1 |
Ryu, S | 1 |
Fujita, S | 1 |
Matsuda, H | 1 |
Ishikawa, Y | 1 |
Komura, S | 1 |
Tanabe, Y | 1 |
Washizuka, T | 1 |
Yoshisato, T | 1 |
Takeda, H | 1 |
Tsuburaya, R | 1 |
Endo, N | 1 |
Niitsuma, T | 1 |
Miura, E | 1 |
Hirosaka, A | 1 |
Owada, K | 1 |
Tamagawa, K | 1 |
Tada, T | 1 |
Kusano, KF | 2 |
Banba, K | 2 |
Miura, D | 1 |
Ohe, T | 2 |
Kanemori, T | 1 |
Shimizu, H | 1 |
Oka, K | 1 |
Furukawa, Y | 1 |
Hiromoto, K | 1 |
Mine, T | 1 |
Masuyama, T | 1 |
Ohyanagi, M | 1 |
Madias, JE | 1 |
Hiramatsu, S | 1 |
Sakuragi, S | 1 |
4 trials available for pilsicainide and Brugada ECG Pattern
Article | Year |
---|---|
Different effect of the pure Na+ channel-blocker pilsicainide on the ST-segment response in the right precordial leads in patients with normal left ventricular function.
Topics: Adult; Aged; Algorithms; Brugada Syndrome; Electrocardiography; Female; Heart Diseases; Humans; Lido | 2007 |
Discrimination of Brugada syndrome patients from individuals with the saddle-back type ST-segment elevation using a marker of the standard 12-lead electrocardiography.
Topics: Adult; Aged; Arrhythmias, Cardiac; Biomarkers; Brugada Syndrome; Diagnosis, Differential; Electrocar | 2007 |
Clinical significance of macroscopic T-wave alternans after sodium channel blocker administration in patients with Brugada syndrome.
Topics: Brugada Syndrome; Electrocardiography; Female; Humans; Lidocaine; Male; Middle Aged; Sodium Channel | 2008 |
Sodium channel blockers enhance the temporal QT interval variability in the right precordial leads in Brugada syndrome.
Topics: Brugada Syndrome; Electrocardiography; Electrophysiologic Techniques, Cardiac; Female; Heart Rate; H | 2008 |
28 other studies available for pilsicainide and Brugada ECG Pattern
Article | Year |
---|---|
Pilsicainide Administration Unmasks a Phenotype of Brugada Syndrome in a Patient with Overlap Syndrome due to the E1784K SCN5A Mutation.
Topics: Adult; Anti-Arrhythmia Agents; Brugada Syndrome; Electrocardiography; Humans; Lidocaine; Long QT Syn | 2020 |
Utility of 12-lead and signal-averaged Holter electrocardiograms after pilsicainide provocation for risk stratification in Brugada syndrome.
Topics: Anti-Arrhythmia Agents; Brugada Syndrome; Electrocardiography, Ambulatory; Female; Humans; Lidocaine | 2017 |
Prognostic Significance of the Sodium Channel Blocker Test in Patients With Brugada Syndrome.
Topics: Administration, Intravenous; Adult; Aged; Brugada Syndrome; Death, Sudden, Cardiac; Electrocardiogra | 2018 |
Clinical and Electrocardiographic Differences in Brugada Syndrome With Spontaneous or Drug-Induced Type 1 Electrocardiogram.
Topics: Adult; Anti-Arrhythmia Agents; Brugada Syndrome; Electrocardiography; Female; Humans; Lidocaine; Mal | 2019 |
Significance of electrocardiogram recording in high intercostal spaces in patients with early repolarization syndrome.
Topics: Adult; Anti-Arrhythmia Agents; Brugada Syndrome; Electrocardiography; Electrophysiologic Techniques, | 2016 |
Right coronary cusp as a new window of ablation for pilsicainide-induced ventricular premature contractions in a patient with Brugada syndrome.
Topics: Adult; Brugada Syndrome; Electrocardiography; Electrophysiologic Techniques, Cardiac; Heart Ventricl | 2016 |
A Novel SCN5A Mutation Associated with Drug Induced Brugada Type ECG.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Base Sequence; Brugada Syndrome; | 2016 |
Action potential alternans in the right ventricular outflow tract in a patient with asymptomatic Brugada syndrome.
Topics: Action Potentials; Aged; Anti-Arrhythmia Agents; Brugada Syndrome; Electrocardiography; Humans; Lido | 2009 |
Ischemia-induced Brugada-type ST-segment alternans and Brugada syndrome.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Brugada Syndrome; Bundle-Branch Block; Coronary Artery | 2010 |
Pilsicainide-induced ST segment elevation and ST segment depression in two patients with variant forms of Brugada-type electrocardiographic abnormalities.
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Brugada Syndrome; Electrocardiography; Humans; Injections | 2009 |
A predictor of positive drug provocation testing in individuals with saddle-back type ST-segment elevation.
Topics: Action Potentials; Adult; Brugada Syndrome; Electrocardiography; Female; Humans; Infusions, Intraven | 2009 |
Ventricular late potential in patients with apparently normal electrocardiogram; predictor of Brugada syndrome.
Topics: Adult; Aged; Aged, 80 and over; Brugada Syndrome; Chi-Square Distribution; Electrocardiography; Fema | 2010 |
Conduction delay in right ventricle as a marker for identifying high-risk patients with Brugada syndrome.
Topics: Adult; Anti-Arrhythmia Agents; Brugada Syndrome; Coronary Sinus; Death, Sudden, Cardiac; Electrocard | 2010 |
A novel microsatellite polymorphism of sodium channel beta1-subunit gene (SCN1B) may underlie abnormal cardiac excitation manifested by coved-type ST-elevation compatible with Brugada syndrome in Japanese.
Topics: Adult; Age Factors; Aged; Asian People; Brugada Syndrome; Electrocardiography; Female; Genetic Predi | 2010 |
Genotype-phenotype correlation in tissue models of Brugada syndrome simulating patients with sodium and calcium channelopathies.
Topics: Action Potentials; Adrenergic beta-Agonists; Animals; Anti-Arrhythmia Agents; Body Surface Potential | 2010 |
What variables were associated with the inducibility of ventricular fibrillation during electrophysiologic stimulation test in patients without apparent organic heart disease?
Topics: Brugada Syndrome; Electric Stimulation; Electrocardiography; Female; Humans; Lidocaine; Male; Middle | 2010 |
Ventricular fibrillation diagnosed during electrophysiological study for non-sustained tachycardia.
Topics: Adult; Anti-Arrhythmia Agents; Brugada Syndrome; Electrocardiography; Humans; Japan; Lidocaine; Male | 2010 |
A new criteria differentiating type 2 and 3 Brugada patterns from ordinary incomplete right bundle branch block.
Topics: Adult; Anti-Arrhythmia Agents; Brugada Syndrome; Bundle-Branch Block; Diagnosis, Differential; Elect | 2011 |
Right ventricular dysfunction in patients with Brugada-like electrocardiography: a two dimensional strain imaging study.
Topics: Brugada Syndrome; Echocardiography; Elasticity Imaging Techniques; Electrocardiography; Female; Huma | 2011 |
The full stomach test as a novel diagnostic technique for identifying patients at risk of Brugada syndrome.
Topics: Adult; Brugada Syndrome; Circadian Rhythm; Electrocardiography; Electrophysiologic Techniques, Cardi | 2006 |
High-frequency potentials developed in wavelet-transformed electrocardiogram as a novel indicator for detecting Brugada syndrome.
Topics: Action Potentials; Adrenergic beta-Agonists; Adult; Aged; Anti-Arrhythmia Agents; Brugada Syndrome; | 2006 |
Temperature modulation of ventricular arrhythmogenicity in a canine tissue model of Brugada syndrome.
Topics: Action Potentials; Animals; Body Temperature; Brugada Syndrome; Disease Models, Animal; Dogs; Electr | 2007 |
How can a single mutation cause such arrhythmic havoc?
Topics: Action Potentials; Animals; Body Temperature; Brugada Syndrome; Disease Models, Animal; Dogs; Electr | 2007 |
Incidence and initial characteristics of pilsicainide-induced ventricular arrhythmias in patients with Brugada syndrome.
Topics: Adult; Aged; Arrhythmias, Cardiac; Brugada Syndrome; Electrocardiography; Electrophysiologic Techniq | 2007 |
[Elderly Brugada syndrome with recurrent syncope, diagnosed by pilsicainide challenge test].
Topics: Aged; Brugada Syndrome; Electrocardiography; Humans; Lidocaine; Male; Recurrence; Syncope | 2007 |
Pilsicainide-induced Brugada-type ECG and ventricular arrhythmias originating from the left posterior fascicle in a case with Brugada syndrome associated with idiopathic left ventricular tachycardia.
Topics: Anti-Arrhythmia Agents; Brugada Syndrome; Catheter Ablation; Electrocardiography; Electrophysiologic | 2008 |
Re: Clinical significance of macroscopic T-wave alternans after sodium channel blocker administration in patients with Brugada syndrome.
Topics: Brugada Syndrome; Electrocardiography; Female; Humans; Lidocaine; Male; Middle Aged; Sodium Channel | 2008 |
Longer repolarization in the epicardium at the right ventricular outflow tract causes type 1 electrocardiogram in patients with Brugada syndrome.
Topics: Action Potentials; Adult; Aged; Brugada Syndrome; Case-Control Studies; Electrocardiography; Endocar | 2008 |